Issue Code: PHA
1,769
452
274
2025--2026
LMH STRATEGIC SOLUTIONS
62 activities
MARSHALL & POPP, LLC
49 activities
MEHLMAN CONSULTING, INC.
46 activities
TODD STRATEGY GROUP
HOUSE OF REPRESENTATIVES
1,426 mentionsSENATE
1,409 mentionsHealth & Human Services, Dept of (HHS)
380 mentionsCenters For Medicare and Medicaid Services (CMS)
DJP SOVEREIGNTY ADVISORS
via DJP SOVEREIGNTY ADVISORS
Proposals, amendments, and federal initiatives relating to domestic manufacturing, supply chain resiliency, and technological sovereignty under the CHIPS and Science Act framework. Executive branch and legislative actions concerning federal tax credits, domestic sourcing, and Foreign Entity of Concern (FEOC) compliance mitigation. Specific provisions related to the STRIDE Act (CHIPS 2.0), regarding National Thermal Shield Deployment, advanced technology supply chain corridors, and FEOC mitigation strategies utilizing international trade manufacturing stacks. Public policy and regulatory frameworks impacting healthcare delivery networks, pharmaceutical development, biotechnology, and corporate financial compliance.
STOKES PHARMACY
via POLITICAL CAPITAL, LLC
FDA Guidance Documents FDA PCAC Safe Drug Legislation
8 activities
41 activities
B HALL STRATEGIES, LLC
39 activities
RUBICON ADVISORS, LLC
37 activities
BALLARD PARTNERS
34 activities
DLA PIPER LLP (US)
32 activities
BGR GOVERNMENT AFFAIRS
29 activities
BUCHANAN INGERSOLL & ROONEY PC
28 activities
Food & Drug Administration (FDA)
182 mentionsWhite House Office
151 mentionsExecutive Office of the President (EOP)
106 mentionsOffice of Management & Budget (OMB)
36 mentionsHealth Resources & Services Administration (HRSA)
36 mentionsCommerce, Dept of (DOC)
30 mentionsKAISER FOUNDATION HEALTH PLAN INC
via KAISER FOUNDATION HEALTH PLAN INC.
Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.527 - Prescription Pricing for the People Act S.1040 - Drug Competition Enhancement Act S.1041 - Affordable Prescriptions for Patients Act S.1097 - Interagency Patent Coordination and Improvement Act S.1095 - Stop STALLING Act S.1096 - Preserve Access to Affordable Generics and Biosimilars Act S.1553 - PREVAIL Act S.1546 - Patent Eligibility Restoration Act of 2025
TRAVERE THERAPEUTICS
via THE HEALTH EQUITY STRATEGIES GROUP, LLC
Rare kidney disease
AMERICAN PHARMACISTS ASSOCIATION
via AMERICAN PHARMACISTS ASSOCIATION
PBM reform Pharmacist payment reform
SYNGENERX HEALTH
via ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)
Updated FDA regulation around the use of Testosterone
WORLD ACTION NETWORK
via WORLD ACTION NETWORK
Everything, with a primary focus on promoting social welfare for business capital for new businesses and jobs, and economic development, and then other supplementary areas.
AMBIOPHARM INC.
via THORN RUN PARTNERS
Advocacy related to U.S. trade, tax, and manufacturing policy, including matters affecting pharmaceutical manufacturing, supply chain resilience, and domestic production of active pharmaceutical ingredients (APIs).
SOLENO THERAPEUTICS, INC.
via SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
EXELIXIS, INC.
via W STRATEGIES, LLC
Education about access to prescription drugs.